zetomipzomib

DRUG2 trials

Sponsors

Kezar Life Sciences, Inc.

Conditions

Autoimmune HepatitisLupus Nephritis

Phase 2

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

CompletedNCT05569759

Kezar Life Sciences, Inc.Autoimmune Hepatitis

Start: 2023-05-23End: 2025-04-30Updated: 2026-01-13

A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

TerminatedNCT05781750

Kezar Life Sciences, Inc.Lupus Nephritis

Start: 2023-11-03End: 2024-11-08Updated: 2025-12-05